The prognostic significance of plasma components including APOA1, apolipoprotein B (APOB), total cholesterol, TG, HDL, and LDL for the various stages of the disease was assessed in 2019, according to the ISS, in a study involving 307 patients with MM [69]. This evidence concerns the gene APOB and Miyoshi myopathy.